Decellularized scaffolds for tissue engineering: Current status and future perspective.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Transplantation Biology

Background:

• Over 113,000 patients require organ transplants, but only 36,000 received them in a recent year, highlighting a critical gap.
• Conventional submersion decellularization is limited to simple tissues, hindering the development of complex bioartificial organs.
• Perfusion decellularization overcomes limitations, enabling the creation of intricate tissue-engineered scaffolds from organs.

Purpose of the Study:

• To explore the potential of decellularized scaffolds for bioartificial organ generation.
• To highlight the advantages of perfusion decellularization over conventional methods.
• To emphasize the role of extracellular matrix (ECM) components in scaffold function.

Main Methods:

• Review of Organ Procurement and Transplantation Network data.
• Discussion of decellularization techniques, focusing on perfusion decellularization.
• Analysis of the composition and function of extracellular matrix (ECM) in decellularized scaffolds.

Main Results:

• Perfusion decellularization allows for the generation of tissue-engineered scaffolds from complex tissues and entire organs.
• Decellularized scaffolds retain essential extracellular matrix (ECM) components like collagen and elastin.
• These ECM components provide structural and biological functions crucial for tissue engineering.

Conclusions:

• Decellularized scaffolds, particularly those created via perfusion, are a promising approach for bioartificial organ development.
• The inherent properties of ECM components within these scaffolds can be leveraged for regenerative medicine applications.
• Advancements in decellularization techniques are crucial for addressing the organ transplantation shortage.